Physician profile
Ran Lee
NPI 1518220136
$4,959.31
in general payments reported to CMS, 2019-2025
9 companies · $551 in 2025
The $551 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.30 · 2023: $4,131 · 2024: $265 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,200 · Food and Beverage: $1,105 · Travel and Lodging: $642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,200.00 |
| Food and Beverage | $1,105.42 |
| Travel and Lodging | $641.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $2,337.74 | 2023-2024 | Cardiosave Hybrid, Type B Plug, Vasoview Hemopro 2, Base Unit Servo-U |
| Maquet Cardiovascular L.L.C. | $1,600.00 | 2023 | Cardiosave Hybrid, Type B Plug |
| Abiomed | $410.32 | 2023-2025 | Impella |
| Paragonix Technologies, INC. | $349.77 | 2025 | |
| Datascope Corp. | $95.77 | 2023 | Cardiosave Hybrid, Type B Plug |
| Angiodynamics, INC. | $58.39 | 2024-2025 | Alphavac |
| Medtronic, INC. | $55.55 | 2023 | Corevalve Evolut R |
| Ethicon US, LLC | $39.47 | 2024 | Stratafix, Monocryl |
| Abbott Laboratories | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ran Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.